Müller-Längle, A.; Lutz, H.; Hehlgans, S.; Rödel, F.; Rau, K.; Laube, B.
NMDA Receptor-Mediated Signaling Pathways Enhance Radiation Resistance, Survival and Migration in Glioblastoma Cells—A Potential Target for Adjuvant Radiotherapy. Cancers 2019, 11, 503.
https://doi.org/10.3390/cancers11040503
AMA Style
Müller-Längle A, Lutz H, Hehlgans S, Rödel F, Rau K, Laube B.
NMDA Receptor-Mediated Signaling Pathways Enhance Radiation Resistance, Survival and Migration in Glioblastoma Cells—A Potential Target for Adjuvant Radiotherapy. Cancers. 2019; 11(4):503.
https://doi.org/10.3390/cancers11040503
Chicago/Turabian Style
Müller-Längle, Adriana, Henrik Lutz, Stephanie Hehlgans, Franz Rödel, Kerstin Rau, and Bodo Laube.
2019. "NMDA Receptor-Mediated Signaling Pathways Enhance Radiation Resistance, Survival and Migration in Glioblastoma Cells—A Potential Target for Adjuvant Radiotherapy" Cancers 11, no. 4: 503.
https://doi.org/10.3390/cancers11040503
APA Style
Müller-Längle, A., Lutz, H., Hehlgans, S., Rödel, F., Rau, K., & Laube, B.
(2019). NMDA Receptor-Mediated Signaling Pathways Enhance Radiation Resistance, Survival and Migration in Glioblastoma Cells—A Potential Target for Adjuvant Radiotherapy. Cancers, 11(4), 503.
https://doi.org/10.3390/cancers11040503